ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638646 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638646; 2) Community: the network communities that were significantly associated with the response to NSC 638646; 3) Molecule: the relationships between components within communities and NSC 638646; 4) MDR: the compounds that were significantly associated with the NSC 638646.

NSC Compound Enrichment Correlation
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.0171439890681608 0.50234219
NSC 113951 6-Bromotoyocamycin 0.0171439890681608 0.52057642
NSC 330500 Macbecin II 0.0171439890681608 0.45787877
NSC 380721 Eremantholide B 0.0171439890681608 0.46116985
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0171439890681608 0.42878015
NSC 603553 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-methoxy phenyl)-, hydrochloride 0.0171439890681608 0.48683184
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0171439890681608 0.41406137
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.0171439890681608 0.16003638
NSC 633203 Null 0.0171439890681608 -0.19502933
NSC 659319 Null 0.0171439890681608 0.030050978
Total:122  Current:58    [First] [Prev] [Next] [Last]